NCT04602533
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04602533
Title Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael Hopp
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Klinik Löwenstein gGmbH Löwenstein Baden-Würtemberg 74245 Germany Details
Klinikverbund Allgäu gGmbH Immenstadt im Allgäu Bavaria 87509 Germany Details
Asklepios Fachkliniken Muenchen Gauting München Gauting Bavaria 82131 Germany Details
Klinikum Ernst von Bergmann Potsdam Brandenburg 14467 Germany Details
Universitätsklinikum Gießen Marburg Giessen Hesse 35392 Germany Details
Klinikum Kassel GmbH-Klinik für Onkologie und Hämatologie Kassel Hesse 34125 Germany Details
Sana-Klinikum Offenbach Offenbach Hesse 63069 Germany Details
Universitätsmedizin Rostock Rostock Mecklenburg-Vorpommern 18059 Germany Details
Universitätsklinikum Aachen Aachen North Rhine-Westphalia 52074 Germany Details
Lungenklinik Köln-Merheim Cologne North Rhine-Westphalia 51109 Germany Details
KEM GmbH Essen North Rhine-Westphalia 45136 Germany Details
Universitätsklinikum Essen Essen North Rhine-Westphalia 45147 Germany Details
Lungenklinik Hemer Hemer North Rhine-Westphalia 58675 Germany Details
Johannes Wesling Klinikum Minden Minden North Rhine-Westphalia 32429 Germany Details
Helios Kliniken Erfurt Erfurt Thuringia 99089 Germany Details
Asklepios Klinikum Hamburg Hamburg 21075 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field